SYNDAX PHARMACEUTICALS INC shareholders Q3 2023

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

SYNDAX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 2,555,555$37,106,6590.58%
Frazier Life Sciences Management, L.P. 600,000$8,712,0000.58%
Parkman Healthcare Partners LLC 212,448$3,084,7450.56%
Sofinnova Investments, Inc. 600,000$8,712,0000.55%
Ikarian Capital, LLC 2,500$3,630,0000.44%
Sofinnova Investments, Inc. 450,000$6,534,0000.41%
Orbimed Advisors 1,284,000$18,643,6800.40%
ALGERT GLOBAL LLC 456,219$6,6240.31%
Nantahala Capital Management 240,031$3,485,2500.30%
Caption Management, LLC 1,295,300$18,807,7560.29%
Nantahala Capital Management 200,000$2,904,0000.25%
Crestline Management, LP 134,464$1,952,4170.23%
Lion Point Capital, LP 34,500$500,9400.22%
HighVista Strategies LLC 29,490$428,1950.20%
OCCUDO QUANTITATIVE STRATEGIES LP 88,208$1,280,7800.17%
Soleus Capital Management, L.P. 119,500$1,735,1400.16%
Hudson Bay Capital Management LP 2,472,372$35,898,8420.14%
Frazier Life Sciences Management, L.P. 600,000$1,566,0000.10%
Caption Management, LLC 430,800$6,255,2160.10%
PEREGRINE CAPITAL MANAGEMENT LLC 219,974$3,194,0220.10%
External links

This page lists SYNDAX PHARMACEUTICALS INC's shareholders in Q3 2023. To view SYNDAX PHARMACEUTICALS INC's shareholder history, click here.